@inproceedings{inproceedings, title  = {{UPDATED SURVIVAL, QUALITY OF LIFE (QOL), AND SAFETY DATA OF RADIUM-223 CHLORIDE (RA-223) IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASES FROM THE PHASE 3 DOUBLE-BLIND, RANDOMIZED, MULTINATIONAL STUDY (ALSYMPCA)}},

 url = {{}},

 year = {{2012}},

 month = {{9}},

 author = {{Parker C and Coleman RE and Nilsson S and Vogelzang N and Lloyd AJ and Staudacher K and van Gool R and Sartor AO}},

 volume = {{23}},

 journal = {{ANNALS OF ONCOLOGY}},

 pages = {{296-296}},

 note = {{Accessed on 2025/10/10}}}